Welcome : Guest

FDC Ltd. (India) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about FDC Ltd., which is principally involved in Pharmaceuticals Business. Illustrated with 102 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-12616
Price: $3500
Company Type: Public
Pages: 104
Date: March 2016
Market Data Tables: 102

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: FDC Ltd.’s (Operations) Sales by Geographic Region Worldwide (2014-2015) in Percentage for India and Others......3
Pharmaceuticals......4
Table 2: Generic Pharmaceuticals Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Diabetes, Hormonal Drugs, Oncology, Respiratory, Rheumatology, and Others......4
Table 3: New Pharmaceutical Licensed Drugs Market by Indication Worldwide (2014) - Percentage Share Breakdown by Value Sales for AIDS, Diabetes, Diabetes (DPP4), Hepatitis B, Hypertension, and Others......5
Table 4: Lifestyle Therapies by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Anti-Diabetic, Neuro and Cognitive Neuroscience Society (CNS), Pain, Vitamins, Minerals and Nutrients, and Others......6
Table 5: Government Spending on Drugs by Category in Australia (2014) - Percentage Market Share Breakdown by Sales for Acid Blockers, Analgesics, Anti-Cancer, Anti-Diabetes, Antihypertensives, Anti-Lipids, Anti-Obstructive Airway Disease, Immunosuppress, Ophthalmologicals, Psychoanaleptics, Psycholeptics, and Others......7
Table 6: Hospital Drug Market by Segment in China (2015) - Percentage Share Breakdown by Value for Anti-Infection, Cardio-Cerebral Vascular, Digest, Neurology, Oncology and Others......8
Table 7: Patent Medicines Sales by Drugs in China (2015) - Percentage Share Breakdown by Value for Cardio-Cerebrovascular Drugs, Digestive System Drugs, Drugs for Deoplastic Diseases, Gynecological Drugs, Musculoskeletal Drugs, Nervous System Drugs, Respiratory System Drugs, Urinary System Drugs and Others......9
Table 8: Pharmaceuticals Market by Therapeutic Area in China (2014) - Percentage Share Breakdown by Value Sales for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular Diseases, Musculo-Skeletal System, Nervous System, Oncology, Respiratory System, Systemic Anti- Infective, and Others......10
Table 9: Traditional Chinese Medicine (TCM) Market for Cardiovascular by Drug in China (2015) - Percentage Share Breakdown by Value for Fufang Danshen Dripping Pill, Naoxintong Capsule and Others......11
Table 10: Traditional Chinese Medicine (TCM) Market for Cerebral Nervous System by Drug in China (2015) - Percentage Share Breakdown by Value for Tianmasuo Injection, Wuling Capsule, Yangxue Qongnal Granule and Others......12
Table 11: Pharmaceuticals Market by Therapeutic Area in China (2015) - Percentage Share Breakdown by Value for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular System, Nervous System, Oncology and Immunomodulating Agents, Systemic Anti-infectives, Musculo-Skeletal System and Others......13
Table 12: Formulations Sales by Category in India (2014) - Percentage Market Share Breakdown by Value for Anti Infective, Anti-Diabetic, Central Nervous System (CNS), Cyclic Vomiting Syndrome (CVS), Gastrointestinal, Pain Management, and Others......14
Table 13: Special Treatment Drugs Market by Group in Vietnam (2015) - Percentage Share Breakdown by Value for Cardiovascular Group, Metabolism Group, Neurology, Sterilization Group and Others......15
Analgesic Molecules......16
Table 14: Analgesic Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Aspirin, Ibuprofen, Paracetamol and Others......16
Biologics......17
Table 15: No. of Biologics in Development by Therapeutic Area Worldwide (2014) - Percentage Market Share Breakdown for Autoimmune Disorders, Blood Disorders, Cancer/Related Conditions, Cardiovascular Disease, Diabetes/Related Conditions, Digestive Disorders, Eye Conditions, Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Neurologic Disorders, Respiratory Disorders, Skin Diseases, Transplantation, and Others......17
Table 16: Therapeutic Biologics Market by Type in China (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others......18
Table 17: Biologics Therapeutic Classes Market by Category in China (2014) - Percentage Share Breakdown by Value for Cardiovascular, CNS, Dermatology, Hematology, Metabolic, Musculoskeletal, Oncology, Urinary, and Others......19
Cardiovascular Market......20
Table 18: Cardiovascular Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......20
Table 19: Cardiac & Vascular Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Americas, Asia and Others, Europe, and Japan......21
Cardiology Market......22
Table 20: Cardiology Market by Category in the US (2014) - Percentage Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Anti-Arrhythmics, ARB's, Beta Blockers, Calcium Blockers, Cholesterol, Digitalis, Diuretics, Vasodilators, and Others......22
Table 21: Cardiology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cardiac Rhythm Management & Congestive Heart Failure Devices, Cardiac Surgery, and Interventional Cardiology......23
Dermatology Drugs......24
Table 22: Anti-acne Topical Dermatology Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Acne, AK + Psoriasis + Dermatitis + Others, Anti-Fungal Combo, Anti-Infective, Coagulants, Corticosteroids Combo, and Corticosteroids Plain......24
Table 23: Dermatology Drugs Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for France, Germany, Italy, Japan, Spain, UK, US, and Rest of World......25
Table 24: Dermatological Therapeutics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Anti-Acne, Anti-Infectives, Anti-Psoriasis, Corticosteroids, Topical and Other Dermatological Drugs, and Others......26
Dermatology Market......27
Table 25: Dermatology Biologics Market by Product Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and STELARA......27
Diabetes Drugs......28
Table 26: Anti-Diabetic Drug Market by Treatment Class Worldwide (2014) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......28
Table 27: Diabetes/Metabolic Drugs Market by Category Worldwide (2014) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......29
Table 28: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......30
Table 29: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......31
Table 30: Therapeutics Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Antidiabetics, Asthma/COPD, Autolmmune, Lipid Regulators, Oncologicsm, and Others......32
Table 31: Therapeutic Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Cancer/Onc./Hem., Cardiology, CNS, Dermatology, Diabetes, GI/Ulcer, Infectious Disease, Multiple Sclerosis, Ophthalmology, Respiratory, Rheumatology, Women's Health, and Others......33
Table 32: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......34
Table 33: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......35
Table 34: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......36
Table 35: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......37
Table 36: Therapeutic Classes Market by Segment in the US (2014) - Percentage Market Share Breakdown by Value Sales for Antidiabetics, Antihypertensives, Autoimmune Diseases, HIV Antivirals, Lipid Regulators, Mental Health, Oncologics, Pain, Respiratory Agents, and Others......38
Diabetic Macular Edema (DME)......39
Table 37: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......39
Table 38: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2014) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......40
Diabetes Market......41
Table 39: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type‐1 Diabetes, Insulin Type‐2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP‐1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others (includes Sodium-Glucose Co-Transporter-2 (SGLT2), Biguanide, Sulfonylurea, Alpha-Glucosidase Inhibitors, Peroxisome Proliferator-Activated Receptor (PPAR)......41
Table 40: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......42
Table 41: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......43
Table 42: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......44
Table 43: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......45
Table 44: Type 1 Diabetes Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Continuous Glucose Monitoring Users, and Non-Continuous Glucose Monitoring Users......46
No. of Diabetes Patients......47
Table 45: Diagnosed Narcolepsy Patients Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Current Xyrem Patient, Untreated Diagnosed Patients and WF Peak Additional Xyrem Patients......47
Table 46: No. of Diabetes Patients by Medication in the US (2014) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......48
Dietary Supplements......49
Table 47: Dietary Supplements Retail Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Fish Oil, Glucosamine, Krill Oil, Magnesium, Multi-Vitamins, Vitamin B, Vitamin C, Vitamin D, Other Herbal, and Others......49
Table 48: Dietary Supplements Market by Distribution Channels in the US (2015) - Percentage Share Breakdown by Value for Health Food and Specialized Stores, Healthcare Practitioners, Internet, Mail Order, TV, and Radio, Mass Market, and Multi-level Marketing......50
Table 49: Dietary Supplements Market by Nutrients in the US (2015) - Percentage Share Breakdown by Value for Herbal and Botanical Supplements, Meal Supplements, Mineral Supplements, Specialty Supplements, Sports Supplements, and Vitamin Supplements......51
Gastrointestinal Drugs......52
Table 50: Gastrointestinal Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for H2 Blockers, Proton Pump Inhibitors, and Others......52
Table 51: Therapy Market by Type in Russia (2015) - Percentage Share Breakdown by Value for Gastrointestinal, Pain, Respiratory, Vitamins, and Others......53
Gastroparesis......54
Table 52: Gastroparesis Market by Cause Worldwide (2015) - Percentage Share Breakdown by Volume for Diabetic, Idiopathic, Surgery and Other......54
Table 53: Gastroparesis Market by Cause in the US (2015) - Percentage Share Breakdown by Value for Diabetic, Idiopathic, Surgery and Other......55
Ophthalmic Drugs......56
Table 54: Ophthalmic Antibiotic Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Besivance, Moxeza, Vigamox, Zymaxid and Generic & Others......56
Table 55: Ophthalmic Steroid Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Alrex, Durezol, Lotemax, Ozurdex and Generic & Others......57
Glaucoma Drugs......58
Table 56: Glaucoma Drugs Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonists (AA), Beta Blocker Fixed Combos (BB-FC), Beta Blockers (BB), Carboic Anhydrase Inhibitors (CAI) and Prostaglandins (PGA)......58
Table 57: Glaucoma Disease Market for Prostaglandin Analogs (PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Latanoprost, Lumigan, Travatan and Others......59
Table 58: Glaucoma Disease Market for Non Prostaglandin Analogs (Non-PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blockers (alone), Beta Blockers (combo), Canbone Anymore and Others......60
Table 59: Glaucoma Market by Product in the US (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blocker, Beta Blocker Fixed Combo, Bimatoprost (Lumigan), Carbonic Anhydrase Inhibitor, Latanoprost (Xalatan, Generics), Travoprost (Travatan), and Others......61
Ophthalmology Market......62
Table 60: Ophthalmology Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Ophthalmic pharmaceuticals, Surgical, and Vision Care......62
Table 61: Ophthalmology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cataract & Vitreoretinal Surgery, Ophthalmic Lasers, and Vision Care......63
Respiratory Drugs......64
Table 62: Respiratory Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue, and Rhinitis......64
Table 63: Respiratory Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Allegra and Telfast, Claritin and Clarinex, Flixotide and Flovent, Seretide and Advair, Spiriva, Symbicort, Xolair, and Others......65
Table 64: Respiratory Therapeutic Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue and Rhinitis......66
Table 65: Anaesthesia and Respiratory Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Anaesthesia Delivery Systems, Anaesthesia Disposables, Nebulizers, Oxygen Therapy Devices, Ventilators, and Others......67
Table 66: Specialty Respiratory Conditions Drugs Benefit Market by Category in the US (2015) - Percentage Share Breakdown by Value for Medical Benefit and Pharmacy Benefit......68
Anesthesia & Respiratory Products......69
Table 67: Market Shares of Leading Anaesthesia & Respiratory Products Manufacturers by Value Sales Worldwide (2015) - Percentage Breakdown for Braun & Company Limited, CareFusion Corporation, Covidien Public Limited Company, Smiths Group Plc, Teleflex, Inc., Vital Signs, Inc., and Others......69
Table 68: Market Shares of Leading Anesthesia & Respiratory Companies Worldwide (2015) - Percentage Share Breakdown by Value for Braun AG, CareFusion, Covidien Public Limited Company, Smiths Group Plc, Teleflex Incorporated, Vital Signs, Inc., and Others......70
Analgesics Drugs......71
Table 69: Market Shares of Leading Analgesics Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Pfizer, Inc., Reckitt Benckiser Plc, and Others......71
Table 70: Market Shares of Leading Anaesthetics & Analgesics Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......72
Table 71: Market Shares of Leading Analgesics Manufacturers in Africa Middle East (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Reckitt Benckiser Group and Others......73
Table 72: Market Shares of Leading Analgesics Manufacturers in Asia-Pacific (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Reckitt Benckiser Group and Others......74
Table 73: Market Shares of Leading Drug (Analgesics Capsule) Companies in China (2015) - Percentage Breakdown by Value for Beijing Novartis Pharma Ltd., GlaxoSmithKline (Tianjin) Co., Ltd., Tibet Cheezheng Tibetan Medicine Company Ltd., Yunnan Baiyao Group, and Others......75
Table 74: Market Shares of Leading Analgesics Manufacturers in Europe (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Reckitt Benckiser Group and Others......76
Table 75: Market Shares of Leading Analgesic Product Manufacturers in India (2015) - Percentage Share Breakdown by Value for Emami Ltd., Glaxo SmithKline Consumer Healthcare Ltd., Reckitt Benckiser Group Plc, and Others......77
Table 76: Market Shares of Leading Analgesic Products Brands in India (2015) - Percentage Share Breakdown by Value for Zandu Balm & Mentha Balm, and Others......78
Table 77: Market Shares of Leading Analgesics Brands in Indonesia (2015) - Percentage Share Breakdown by Volume for Bodrex (regular), Oskadon, Paramex, Puyer 16 and Others......79
Table 78: Market Shares of Leading Analgesics Manufacturers in Latin America (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson and Others......80
Table 79: Market Shares of Leading Analgesic Brands in Nigeria (2015) - Percentage Breakdown by Value for Alabukun, Emzor, Pandol, and Others......81
Table 80: Market Shares of Leading Analgesics Manufacturers in North America (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson and Others......82
Table 81: Market Shares of Leading Analgesic (Internal Tablet) Manufacturers by Value Sales at Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Breakdown for Bayer Consumer Health Division, McNeil Consumer Products, Pfizer, Inc., Private Label, and Others......83
Diabetes Drugs......84
Table 82: Market Shares of Leading Drug Sales for GLP-1 based Diabetes Worldwide (2014) - Percentage Breakdown by Value for Albilgutide, Bydureon, Byetta, Dulaglutide, Lixumia and Victoza......84
Table 83: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......85
Table 84: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......86
Table 85: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......87
Anti-Infectives......88
Table 86: Market Shares of Leading Anti-Infective Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Bayer AG, Merck & Co., Inc., Vétoquinol S.A., Virbac S.A., Zoetis, Inc. and Other......88
Cardio Cerebral Vascular (CCV) Drugs......89
Table 87: Market Shares of Leading Cardio-Cerebral Vascular (CCV) Drugs Manufacturers in China (2015) - Percentage Share Breakdown by Value for Sihuan Pharmaceutical Holdings Group Ltd., Sanofi S.A., Qilu pharmaceutical Co., Ltd. and Others......89
Cardiology Therapeutics......90
Table 88: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......90
Dermatology Therapeutics......91
Table 89: Market Shares of Leading Dermatological Product Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Pfizer, Inc., Reckitt Benckiser Plc, and Others......91
Table 90: Market Shares of Leading Dermatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Biogen Idec, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, and Others......92
Table 91: Market Shares of Leading Therapeutic Dermatology (excluding Aesthetics) Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Inc. (ABBV), Galderma S.A., GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Pfizer, Inc. (PFE), Amgen, Inc. (AMGN), Valeant Pharmaceuticals Intl, Inc., Dermik Laboratories, and Others......93
Gastrointestinal Drugs......94
Table 92: Market Shares of Leading Gastrointestinal, Ulcer Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson Pfizer, Inc., and Others......94
Table 93: Market Shares of Leading Gastrointestinal (GI) Remedies Manufacturers for Over-the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for GlaxoSmithKline Pharmaceuticals Limited, Johnson & Johnson Private Limited, Novartis Consumer Health, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Private-Label and Others......95
Table 94: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......96
Table 95: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......97
Respiratory Therapeutics......98
Table 96: Market Shares of Leading Respiratory Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......98
Ophthalmology Therapeutics......99
Table 97: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......99
Ophthalmic Steroids......100
Table 98: Market Shares of Leading Ophthalmic Steroids Brands in the US (2015) - Percentage Share Breakdown by Value for Fluorometholone, Lotemax, Prednisolone and Others......100
Retinal Drugs......101
Table 99: Market Shares of Leading Retinal Companies Worldwide (2014) - Percentage Share Breakdown by Value for Alcon Incorporated, Bausch & Lomb, Dutch Ophthalmic Research Center International BV, Iridex Corporation, Synergetics, Inc., and Others......101
Dietary Supplements......102
Table 100: Market Shares of Leading Dietary Supplements Brands in India (2015) - Percentage Share Breakdown by Value for Zandu Sona Chandi ChywanPrash Plus & Zandu Kesari Jivan, and Others......102
Table 101: Market Shares of Leading Dietary Supplements Manufacturers in India (2015) - Percentage Share Breakdown by Value for Amway India, Emami Ltd., Heinz India Pvt Ltd., and Others......103
Table 102: FDC Ltd.’s (Operations) Sales by Geographic Region Worldwide (2013-2014) in Percentage for India and Others......104